You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 4,755,534


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,755,534
Title: Propenylamines, pharmaceutical compositions containing them and their use as pharmaceuticals
Abstract:A compound of the formula: ##STR1## wherein the double bond is in the trans configuration and R.sub.1 is a radical of formula IIa, ##STR2## R.sub.2, R.sub.3, R.sub.5, R.sub.7 and R.sub.8 are each hydrogen, R.sub.4 is methyl, and R.sub.6 is a radical of formula IIIa where R.sub.11 is n-butyl, tertiary butyl or phenyl or a chemotherapeutically acceptable acid addition salt thereof; processes for their production, their use as pharmaceuticals and pharmaceutical compositions containing them.
Inventor(s): Stuetz; Anton (Maria Enzersdorf, AT)
Assignee: Sandoz Ltd. (Basel, CH)
Application Number:06/646,724
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 4,755,534

Introduction

United States Patent 4,755,534, issued on July 5, 1988, is a significant patent in the pharmaceutical domain. To fully comprehend its impact and the patent landscape it occupies, it is crucial to delve into the details of its scope, claims, and the broader context of patent law and practice.

Patent Overview

Patent Title and Abstract The patent titled "Pharmaceutical drugs covered by patent 4,755,534" involves the development and application of specific pharmaceutical compounds. The abstract typically provides a brief summary of the invention, including the chemical structures, production processes, and intended uses of these compounds[2].

Scope of the Patent

Claim Analysis The scope of a patent is primarily defined by its claims. These claims outline the specific aspects of the invention that are protected by the patent. For US Patent 4,755,534, the claims would include:

  • Independent Claims: These are the broadest claims that define the invention. They typically include the essential elements necessary to practice the invention.
  • Dependent Claims: These claims are narrower and build upon the independent claims, often adding additional limitations to further define the invention[3].

Claim Structure and Patent Scope

The structure and number of claims can significantly impact the patent's scope. Research has shown that narrower claims, both in terms of length and count, are often associated with a higher probability of grant and a shorter examination process. This is because narrower claims are generally clearer and less likely to be rejected due to overbreadth or lack of clarity[3].

Subject Matter Eligibility

Judicial Exceptions and Practical Applications In the context of pharmaceutical patents, subject matter eligibility is a critical issue. The USPTO's recent guidance updates, such as those from 2024, emphasize the importance of integrating judicial exceptions into practical applications. For a claim to be patent-eligible, it must demonstrate a concrete technological improvement or a meaningful limit on the abstract idea. This principle is crucial in ensuring that the claimed invention provides tangible benefits beyond mere abstract ideas[1].

Examples from Recent Guidance

While the 2024 USPTO guidance update is more focused on AI-related inventions, the principles can be applied broadly. For instance, if a pharmaceutical patent claim involves a mathematical model or data analysis, it must be integrated into a practical application to be considered patent-eligible. This could involve specifying how the compounds are used in a treatment regimen or how they improve a particular medical condition[1].

Patent Landscape and Prior Art

Searching for Prior Art To understand the patent landscape surrounding US Patent 4,755,534, it is essential to conduct thorough prior art searches. Tools such as the USPTO's Patent Public Search, Global Dossier, and resources from international intellectual property offices can be used to identify related patents and applications. This helps in determining the novelty and non-obviousness of the invention, which are key criteria for patentability[4].

International Patent Considerations

Global Patent System Pharmaceutical patents often have global implications. The World Intellectual Property Organization (WIPO) and other international patent offices provide databases and tools to search for patents worldwide. For example, the European Patent Office's esp@cenet and the Japan Patent Office's databases can be used to see if similar inventions have been patented abroad. This is crucial for understanding the global patent landscape and potential infringement risks[4].

Patent Assignment and Ownership

Changes in Ownership The ownership of a patent can change over time due to assignments, mergers, or acquisitions. The USPTO's Patent Assignment Search database allows users to track changes in patent ownership, which is important for licensing, litigation, and other business considerations[4].

Patent Examination and Maintenance

Examination Process and Maintenance Payments The examination process for patents can significantly impact their scope. Narrower claims are often favored during the examination process as they are clearer and less likely to be rejected. Additionally, patent maintenance payments are required to keep the patent in force. The scope of the patent can influence these payments, as broader patents may require more extensive maintenance efforts[3].

Real-World Applications and Benefits

Practical Utility and Benefits For a pharmaceutical patent like US 4,755,534, demonstrating real-world applications and benefits is crucial. The patent must show how the claimed compounds are used in a specific, practical application, such as treating a particular disease or improving patient outcomes. This practical utility is essential for meeting the criteria for patent eligibility and for justifying the patent's existence in the market[1].

Key Takeaways

  • Claim Structure: The scope of the patent is defined by its claims, with narrower claims generally being more favorable.
  • Subject Matter Eligibility: Claims must integrate judicial exceptions into practical applications to be patent-eligible.
  • Prior Art Searches: Thorough searches are necessary to determine novelty and non-obviousness.
  • International Considerations: Global patent databases and tools are essential for understanding the broader patent landscape.
  • Ownership and Maintenance: Tracking changes in ownership and maintaining the patent through required payments are critical.

FAQs

Q: What is the significance of claim structure in patent scope? A: The claim structure, including the length and count of claims, can impact the patent's scope and the likelihood of it being granted. Narrower claims are generally clearer and less likely to be rejected.

Q: How does the USPTO's recent guidance on AI patents apply to pharmaceutical patents? A: While the guidance is focused on AI, the principles of integrating judicial exceptions into practical applications are broadly applicable, ensuring that claims provide tangible benefits beyond abstract ideas.

Q: What tools are available for searching prior art in pharmaceutical patents? A: Tools such as the USPTO's Patent Public Search, Global Dossier, and international patent office databases can be used to identify related patents and applications.

Q: Why is it important to track changes in patent ownership? A: Tracking changes in ownership is crucial for licensing, litigation, and other business considerations, ensuring that the correct parties are involved in any patent-related activities.

Q: How do patent maintenance payments relate to the scope of a patent? A: The scope of the patent can influence the maintenance payments required to keep the patent in force, with broader patents potentially requiring more extensive maintenance efforts.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,755,534

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,755,534

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland7656/79Aug 22, 1979

International Family Members for US Patent 4,755,534

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0024587 ⤷  Subscribe 93C0136 Belgium ⤷  Subscribe
European Patent Office 0024587 ⤷  Subscribe SPC/GB93/096 United Kingdom ⤷  Subscribe
Austria 10272 ⤷  Subscribe
Australia 538928 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.